scispace - formally typeset
D

David S. Bredt

Researcher at Johnson & Johnson

Publications -  224
Citations -  63974

David S. Bredt is an academic researcher from Johnson & Johnson. The author has contributed to research in topics: Nitric oxide synthase & Nitric oxide. The author has an hindex of 107, co-authored 223 publications receiving 62332 citations. Previous affiliations of David S. Bredt include Johns Hopkins University & Georgetown University Medical Center.

Papers
More filters
Journal ArticleDOI

TARP subtypes differentially and dose-dependently control synaptic AMPA receptor gating.

TL;DR: A striking heterogeneity in the effects of TARP subtypes on AMPAR deactivation and desensitization is reported, which is demonstrated controls the time course of synaptic transmission and suggests a variable TARP/AMPAR stoichiometry.
Journal ArticleDOI

Ultrastructural localization of nitric oxide synthase immunoreactivity in guinea-pig enteric neurons.

TL;DR: Results indicate that nitric oxide may regulate the activity of both myenteric neurons and smooth muscle, and leave unanswered the question of how Nitric oxide is stored and released.
Journal ArticleDOI

Characterization of MALS/Velis-1, -2, and -3: a Family of Mammalian LIN-7 Homologs Enriched at Brain Synapses in Association with the Postsynaptic Density-95/NMDA Receptor Postsynaptic Complex

TL;DR: This work suggests a role for MALS proteins in regulating recruitment of neurotransmitter receptors to the PSD, and identifies a family of small synaptic proteins containing little more than a single PDZ domain.
Journal ArticleDOI

Relative sparing of nitric oxide synthase-containing neurons in the hippocampal formation in Alzheimer's disease.

TL;DR: It is shown that NO synthase neurons are selectively spared in patients with Alzheimer's disease, even in a severely affected region of the brain such as the hippocampal formation.
Journal ArticleDOI

From molecules to mammals: what's NOS got to do with it?

TL;DR: This review will outline the data gleaned from complementary knockout and transgenic over-expression models in mice, and focus on the interactions between NOS enzymes and pathophysiology of the vascular system.